CIO

JANUARY 3, 2024

So the top questions that go beyond the usual due diligence that companies must ask when evaluating generative AI vendors have to with training data, copyright, added value, and model independence. That would give the smaller vendors time to innovate further, or give customers time to migrate. It would take six months to a year.”

Alliance 493

Alliance Due Diligence Pharmaceutical Security 493

Alpha Sense BI

FEBRUARY 6, 2024

Clinical Pipelines and Drug Developments – Assessing the pipeline of pharmaceutical and biotechnology companies by analyzing clinical trials to gauge the potential success of new drugs or therapies in development.

Research 98

Research Primary Research Due Diligence Competitive Positioning 98

Alpha Sense BI

MAY 28, 2024

Instead, experts agree that investors will likely turn to innovative start-up companies with promising growth plans and strong leadership teams. Startups that survive the funding drought and succeed in securing allocations will be those with experienced, executive-level leadership and compelling customer-centric solutions.

Capital 69

Capital Startups Biotech Due Diligence 69

Alpha Sense BI

DECEMBER 12, 2023

These intangible factors indicate that even the most exhaustive due diligence processes can still leave gaps in the M&A research process. Comprehensive Due Diligence Thorough due diligence on a target company is undeniably the cornerstone of successful M&A.

Due Diligence 52

Due Diligence Primary Research Competitive Intelligence Market Intelligence 52

Alpha Sense BI

FEBRUARY 3, 2023

Without an official system to check an organization’s commitment to its ESG policies, many shareholders and investors are doing their due diligence through fact-checking. timber, natural pharmaceuticals) and services (i.e., In fact, biodiversity attrition can also severely hinder a company’s bottom line.

Finance 98

Finance Due Diligence Banking Pharmaceutical 98

Alpha Sense BI

MARCH 21, 2024

One AlphaSense customer has saved tens of thousands of dollars by using our AI-search technology to optimize their research at various pharmaceutical companies. However, newer evolutions of the expert network can streamline access to industry experts through innovative technology.

Primary Research 59

Primary Research Due Diligence SWOT Pharmaceutical 59

Alpha Sense BI

DECEMBER 15, 2023

From identifying potential drug candidates and optimizing molecular structures to streamlining clinical trial design and enhancing personalized medicine , this technology is driving unprecedented efficiency and innovation. The integration of these systems enhances operational efficiency, freeing scientists to focus on innovation.

Pharmaceutical 52

Pharmaceutical Algorithm Predictive Analytics Research 52